Changes of HBV Markers in Serum and Liver Tissue in Patients with Chronic Hepatitis B Treated with Recombinant Alpha-Interferon (rIFN-α): Results of a Controlled Study
- 1 October 1990
- journal article
- Published by SAGE Publications in Antiviral Chemistry and Chemotherapy
- Vol. 1 (5) , 329-331
- https://doi.org/10.1177/095632029000100508
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- A controlled trial of human lymphoblastoid interferon in chronic hepatitis B in ItalyHepatology, 1989
- Randomized, controlled trial of recombinant human α-interferon in patients with chronic hepatitis BGastroenterology, 1988
- Recombinant leucocyte interferon treatment of chronic hepatitis B: An analysis of two therapeutic trialsJournal of Hepatology, 1986
- Pilot study of recombinant human α-interferon for chronic type B hepatitisGastroenterology, 1986
- Preliminary trial of recombinant fibroblast interferon in chronic hepatitis B virus infectionAntimicrobial Agents and Chemotherapy, 1986
- Prognostic value of HBeAg in chronic persistent hepatitis.BMJ, 1977